Rosa Cervelli

Rosa Cervelli

Auto-generated profile, based on publicly available information

Rosa Cervelli

Department of Radiological Nuclear and Laboratory Medicine, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in European Journal of Radiology
Verified
Journal Article
Closed access
Piero BoraschiPiero Boraschi
Piero Boraschi
FDFrancescamaria Donati
Francescamaria Donati
RCRosa Cervelli
Rosa Cervelli
FPFederica Pacciardi
Federica Pacciardi
GTGaia Tarantini
Gaia Tarantini
RLRiccardo Lencioni
Riccardo Lencioni

22 October 2020 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
TDTommaso Depalo
Tommaso Depalo
GBGiuseppe Boni
Giuseppe Boni
DGDavide Ghinolfi
Davide Ghinolfi
EBElena Bozzi
Elena Bozzi
RCRosa Cervelli
Rosa Cervelli
IBIrene Bargellini
Irene Bargellini

22 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IBIrene Bargellini
Irene Bargellini
GBGiuseppe Boni
Giuseppe Boni
ATAntonio Traino
Antonio Traino
EBElena Bozzi
Elena Bozzi
GLGiulia Lorenzoni
Giulia Lorenzoni
RCRoberto Cioni
Roberto Cioni
Background: In the context of the coronavirus disease 2019 (COVID-19) pandemic, liver-directed therapies (LDTs) may offer minimally invasive integrative tools for tumor control. Among them, selective internal radiation therapy (SIRT) represents a safe, flexible and effective treatment. Purpose of this study is to present our experience with SIRT during the first wave of COVID-19 pandemic and provide an overview of the indications and challenges of SIRT in this scenario. Methods: We retrospectively analyzed the number of patients evaluated by Multidisciplinary Liver Tumor Board (MLTB) and who were undergoing LDTs between March and July 2020 and compared it with 2019. For patients treated with SIRT, clinical data, treatment details and the best radiological response were collected. Results: Compared to 2019, we observed a 27.5% reduction in the number of patients referred to MLTB and a 28.3% decrease in percutaneous ablations; transarterial chemoembolizations were stable, while SIRT increased by 64%. The majority of SIRT patients (75%) had primary tumors, mostly HCC. The best objective response and disease control rates were 56.7% and 72.2%, respectively. Conclusion: The first wave of the COVID-19 pandemic was characterized by an increased demand for SIRT, which represents a safe, flexible and effective treatment, whose manageability will further improve by simplifying the treatment workflow, developing user-friendly and reliable tools for personalized dosimetry and improving interdisciplinary communication.

1 September 2019 in American Journal of Roentgenology
Verified
Journal Article
Closed access
Piero BoraschiPiero Boraschi
Piero Boraschi
FDFrancescamaria Donati
Francescamaria Donati
FPFederica Pacciardi
Federica Pacciardi
RCRosa Cervelli
Rosa Cervelli
RGRoberto Gigoni
Roberto Gigoni
VTValter Torri
Valter Torri
OBJECTIVE. The objective of our study was to evaluate image quality and reader confidence in MR cholangiography of bile ducts using conventional T2-weighted MR cholangiography alone in comparison w...

19 August 2022 in La radiologia medica
Verified
Journal Article
Closed access
PDF file
RCRosa Cervelli
Rosa Cervelli
MCMatteo Cencini
Matteo Cencini
AIAndrea Cacciato Insilla
Andrea Cacciato Insilla
GAGiacomo Aringhieri
Giacomo Aringhieri
UBUgo Boggi
Ugo Boggi
LCLaura Crocetti
Laura Crocetti

1 January 2021 in International Journal of Hyperthermia
Verified
Journal Article
Open access
laura crocettilaura crocetti
laura crocetti
CAClaudio Amabile
Claudio Amabile
PSPaola Scalise
Paola Scalise
NTNevio Tosoratti
Nevio Tosoratti
EBElena Bozzi
Elena Bozzi
RCRoberto Cioni
Roberto Cioni
To study the correlation between the overall coagulation zone (A) attained in percutaneous microwave ablation (MWA) of hepatocellular carcinomas (HCC) and: (1) the hyperdense zone (C) visible in the central part of zone A on post-treatment unenhanced CT scans; (2) the deposited energy; (3) the coagulation zones observed on ex-vivo bovine liver. The post-procedural computed tomography (CT) scans of HCCs treated with a single energy deployment through the same 2450 MHz MWA system were retrospectively analyzed, retrieving the dimensions of A and C zones and the deposited energy (E). Ex-vivo bovine liver MWA with the same system were performed and analyzed to determine the same quantities by gross-pathologic examination and CT imaging. A total of 101 HCC treatments were analyzed. The average coagulation volumes increased linearly with deposited energy (1.11 cc/kJ, R2 = 0.90, 4.2 kJ ≤ E ≤ 48 kJ), similarly to ex-vivo findings (1.38 cc/kJ, R2 =0.97, 7.2 kJ ≤ E ≤ 144 kJ). The long axis (L) and short axis (D) of zones A and C held a fairly constant ratio both in-vivo (LC/LA=0.43 ± 0.13; DC/DA=0.42 ± 0.10) and ex-vivo (LC/LA = 0.49 ± 0.07; DC/DA = 0.28 ± 0.06). The average dimensions of the ablation zone induced by the considered system on HCC increase linearly with the deposited energy and are fairly well predicted by the corresponding ex-vivo dimensions. The ratio between each linear dimension of A and C zones was found to be roughly constant over a large deposited energy span, both ex-vivo and in-vivo.